Newsday - July 29, 1994
Laurie Garrett. Staff Writer
The larger study, based on 111 male hemophiliacs in England, suggests that up to 25 percent of young men who become infected, but who do not have AIDS, can expect to live 20to 25 years. The smaller study, outlined in a companion commentary written by California state health officials, was more conservative, suggesting that 15 percent would live up to 20 years.
Both studies, presented in today's British Medical Journal, are mathematical models based on observations of subtle, incremental changes in the men's immune systems.
The reasons for the differences in survival rates are not clear.
Earlier research on gay men in San Francisco showed that the mean time following infection and before the onset of AIDS was 10 to 12 years. Survival in other key groups - particularly African men and women - is far shorter, with some dying within two to three years after infection.
The new research contained some strong caveats, however: Both papers deal only with men, offering no basis for projecting female survival; and, most important, both are mathematical models that can only be proved after the passage of a decade.
For 11 years researchers from the School of Medicine, London, closely monitored subtle changes in the men's immune systems - particularly in their CD4 counts, which decline sharply as people infected with HIV grow sicker. The British team, led by Dr. Andrew Phillips, concluded from the CD4 evidence that a minority of them worsen at a snail's pace.
"We have used 11 years of CD4 lymphocyte count experienced in 111 hemophilic men to forecast the probability of survival free of AIDS up to 25 years after infection with HIV," the British researchers write. "The results suggest that such prolonged survival is likely in about a quarter of patients."
Based on similar mathematical methods used to analyze a group of gay men in San Francisco who have been closely monitored since the beginning of the AIDS epidemic, California State Health Officer George Rutherford came up with the 15 percent figure. The number of people being studied was not stated.
940729
ND940701
Copyright © 1994 - Newsday. All rights reserved. All pages of newsday.com are copyright © Newsday, Inc. Other parties may also own rights to portions of newsday.com content. No portion of newsday.com content may be published, broadcast or distributed, directly or indirectly, in any medium without Newsday's prior written consent. Newsday, Inc. will not be held liable for any delays, inaccuracies, errors or omissions in any content on newsday.com. http://www.newsday.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .